Roquefort Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ROQ?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	1,174,209	0.865%
Private Companies	11,007,505	8.11%
Institutions	33,714,927	24.8%
Individual Insiders	44,583,598	32.8%
General Public	45,256,363	33.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 60.83% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.07%	Trevor Reginald	12,311,981	UK£467.9k	5.56%	no data
5.92%	Glenn Whiddon	8,039,774	UK£305.5k	10.1%	no data
5.7%	James Brearley & Sons Ltd.	7,732,188	UK£293.8k	251%	0.15%
5.48%	Abdelatif Lachab	7,440,000	UK£282.7k	-4%	no data
4.65%	Stephen West	6,310,853	UK£239.8k	12.4%	no data
4.23%	Mubasher Sheikh	5,744,870	UK£218.3k	0%	no data
3.54%	Lyramid Limited	4,800,000	UK£182.4k	0%	no data
2.04%	Cantor Fitzgerald Asset Management	2,771,765	UK£105.3k	0%	no data
2.02%	Neue Bank Ag, Asset Management Arm	2,740,000	UK£104.1k	0%	0.13%
1.84%	Hobart Capital Markets Limited, Asset management Arm	2,493,478	UK£94.8k	-30.7%	0.84%
1.71%	IG Group Holdings Plc, Asset Management Arm	2,325,163	UK£88.4k	48.4%	0.01%
1.66%	Chaim Hurvitz	2,249,300	UK£85.5k	0%	no data
1.66%	HBOS Investment Fund Managers Limited	2,246,780	UK£85.4k	132%	no data
1.5%	Darrin Disley	2,033,342	UK£77.3k	35.9%	no data
1.32%	Wrightwood Investments Limited	1,785,715	UK£67.9k	0%	no data
1.28%	Newlords Limited	1,739,774	UK£66.1k	74%	no data
1.24%	Killik Asset Management	1,686,103	UK£64.1k	0%	no data
1.09%	Barclays Bank PLC, Wealth and Investment Management Division	1,473,323	UK£56.0k	66%	no data
1.06%	Charles Stanley & Co. Ltd, Asset Management Arm	1,443,610	UK£54.9k	1,540%	no data
0.73%	Daiichi Sankyo Company Ltd	994,780	UK£37.8k	0%	no data
0.69%	Lloyds Banking Group plc	936,224	UK£35.6k	0%	no data
0.66%	HSBC Global Asset Management (UK) Limited	897,148	UK£34.1k	125%	no data
0.61%	BNY Mellon Advisors, Inc.	825,500	UK£31.4k	-77%	no data
0.58%	M. D. Barnard & Co. Ltd., Asset Management Arm	791,573	UK£30.1k	0%	0.03%
0.56%	Jarvis Securities plc, Asset Management Arm	756,722	UK£28.8k	3,010%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/23 18:43
End of Day Share Price	2025/01/23 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Roquefort Therapeutics plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution